BioNTech to work with Senegal, Rwanda to make mRNA vaccines

Oct 26, 2021, 6:52 AM | Updated: Oct 27, 2021, 7:55 am

DAKAR, Senegal (AP) — Senegal and Rwanda have signed an agreement with German company BioNTech for the construction of its first start-to-finish factories to make messenger RNA vaccines in Africa.

BioNTech, which developed the Pfizer-BioNTech COVID-19 vaccine, said Tuesday that construction will start in mid-2022. It is working with the Institut Pasteur in Dakar, Senegal’s capital, and the Rwandan government, a statement said.

“State-of-the-art facilities like this will be life-savers and game-changers for Africa and could lead to millions of cutting-edge vaccines being made for Africans, by Africans in Africa,” said Matshidiso Moeti, the World Health Organization’s Regional Director for Africa. “This is also crucial for transferring knowledge and know-how, bringing in new jobs and skills and ultimately strengthening Africa’s health security.”

Ugur Sahin, the co-founder and CEO of BioNTech, said its goal is “to develop vaccines in the African Union and to establish sustainable vaccine production capabilities to jointly improve medical care in Africa.”

BioNTech had already agreed in August to work with Rwanda and Senegal to establish facilities in Africa capable of end-to-end manufacturing of mRNA-based vaccines, under license.

The novel mRNA process uses the genetic code for the spike protein of the coronavirus and is thought to trigger a better immune response than traditional vaccines. Scientists hope the technology, which is easier to scale up than traditional vaccine methods, might ultimately be used to make vaccines against other diseases, including malaria.

BioNTech said the facility in Africa will eventually produce about 50 million doses of the vaccine per year, with the capacity to increase.

BioNTech also said it is in discussions for expanding its partnership with the South African vaccine manufacturer Biovac, which is based in Cape Town. Biovac will assemble the vaccine using ingredients provided by BioNTech, a process called fill and finish. That production will begin in 2022 with a goal of reaching more than 100 million finished doses annually.

The BioNTech announcement was criticized by Rohit Malpani, an independent public health consultant in Paris, who previously worked for Doctors Without Borders.

“This is too little too late,” said Malpani. “Nothing should have stopped BioNTech from doing this a year ago when they were building factories in the U.S. and Germany. The fact that they sat on their hands and allowed this vaccine apartheid to proliferate and have left millions of people without vaccines shows that we cannot trust these companies.”

Malpani pointed out that the agreement is to produce the vaccine under license to BioNTech.

“This may expand production, but control over the vaccines still ultimately rests in BioNTech’s hands,” he said. “By the time these vaccines arrive, it will be far too late for millions of people. This does not ensure that countries will have access to vaccines or that they will be able to better respond to future pandemics.”

In contrast, Afrigen Biologics and Vaccines in Cape Town has established a lab and assembled scientists to produce an mRNA vaccine that is a replica of the Moderna vaccine, using information that is publicly available. With backing from the WHO, Afrigen plans to develop and produce an mRNA COVID-19 vaccine independent from Moderna or other big drug companies.

In July, Senegal had announced that the Institut Pasteur would manage a new manufacturing hub to produce vaccines including for COVID-19. The hub was estimated to cost $200 million and would be financed partly by funds from European and U.S. governments and institutions.

These vaccine manufacturing hubs in Africa will help reduce its dependence on imports, as the continent currently relies on imports for about 99% of its vaccine needs, according to the WHO. Africa and its 1.3 billion people remain the least-vaccinated region of the world against COVID-19, with just over 5% fully vaccinated, according to the Africa Centers for Disease Control and Prevention.

___

AP journalist Maria Cheng in London contributed.

Copyright © The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

AP

Associated Press

Woman charged after 1,000 pigs found dead at Iowa site

SAC CITY, Iowa (AP) — An Iowa woman is facing criminal charges after more than 1,000 pigs were found dead on a property. KCCI-TV reports that the Sac County Sheriff’s Office responded to a call Thursday and found the animals dead at two confinement sites. Authorities say 33-year-old Elana Laber was responsible for maintaining the […]
8 hours ago
FILE - Police and other first responders work the scene where officials say dozens of people have b...
Associated Press

Texas’ border mission grows, but crossings still high

AUSTIN, Texas (AP) — Following the horror of a human-smuggling attempt that left 53 people dead, Republican Gov. Greg Abbott ordered state troopers to inspect more trucks — again expanding a border security mission that has cost billions, given the National Guard arrest powers and bused migrants to Washington, D.C. What Abbott’s get-tough plans haven’t […]
8 hours ago
Travelers arrive on foot at Roissy-Charles de Gaulle airport while airport workers demonstrate, lef...
Associated Press

Stuck bags add to tangles at Paris airports amid travel boom

Airlines worked Saturday to deliver luggage to passengers around the world after a technical breakdown left at least 1,500 bags stuck at Paris’ Charles de Gaulle airport, the latest of several tangles hitting travelers this summer. The airport’s baggage sorting system had a technical malfunction Friday that caused 15 flights to depart without luggage, leaving […]
8 hours ago
FILE - In this Feb. 17, 2018, file photo, an early morning fog rises where 17 memorial crosses were...
Associated Press

Parkland jurors must manage trial stress on their own

FORT LAUDERDALE, Fla. (AP) — The jurors chosen this past week to decide whether Florida school shooter Nikolas Cruz is executed will visit a bloodstained crime scene, view graphic photos and videos and listen to intense emotional testimony — an experience that they will have to manage entirely on their own. Throughout what is expected […]
8 hours ago
FILE - An overnight individual egg strata is shown April 4, 2016, in Concord, N.H. Federal regulati...
Associated Press

From AM to PM, the fickle force of government is with you

WASHINGTON (AP) — When you groggily roll out of bed and make breakfast, the government edges up to your kitchen table, too. Unlike you, it’s perky. It’s an unseen force in your morning. The government makes sure you can see the nutrients in your cereal. It fusses over your toast, insisting that the flour it […]
8 hours ago
FILE - Boxes of the drug mifepristone line a shelf at the West Alabama Women's Center in Tuscaloosa...
Associated Press

Medication abortion is common; here’s how it works

Medication abortions became the preferred method for ending pregnancy in the U.S. even before the Supreme Court overturned Roe v. Wade. These involve taking two prescription medicines days apart — at home or in a clinic. Abortion procedures are an invasive medical technique that empties the womb. They are sometimes called surgical abortions, although they […]
8 hours ago

Sponsored Articles

...
Dr. Richard Carmona

Great news: Children under 5 can now get COVID-19 vaccine

After more than two years of battle with an invisible killer, we can now vaccinate the youngest among us against COVID-19. This is great news.
(Courtesy Condor)...
Condor Airlines

Condor Airlines shows passion for destinations from Sky Harbor with new-look aircraft

Condor Airlines brings passion to each flight and connects people to their dream destinations throughout the world.
...
Christina O’Haver

BE FAST to spot a stroke

Every 40 seconds—that’s how often someone has a stroke in the United States. It’s the fifth leading cause of death among Americans, with someone dying of a stroke every 3.5 minutes.
BioNTech to work with Senegal, Rwanda to make mRNA vaccines